Workflow
中医药+
icon
Search documents
除了卖药材,江南药乡浙江磐安还“卖”什么?
Zhong Guo Xin Wen Wang· 2025-11-17 07:30
除了卖药材,江南药乡浙江磐安还"卖"什么? 中新网金华11月17日电(曹丹)一碗天麻焗土鸡,香气里浸润着《本草纲目》的智慧;一杯草本奶茶,奶 香中回味着桂圆、红枣的甘醇;一座乌石古村,黑石民居间流淌着千年的静谧时光。在浙江省金华市磐 安县,这座江南药乡正在经历一场深刻的产业蝶变。 磐安的药香源远流长。晋唐时期,这里已有中药材种植的记载。自唐至元,磐安大盘山所产的13味药材 被列为宫廷贡品;至清代,"磐五味"已负盛名,引得各地药商纷至沓来,成就了"万国皆来市"的盛景。 近年来,磐安通过深入挖掘古代医方,系统整理出古法药膳、餐饮养生、慢病调理等五大品类,研发出 超过200款药膳产品。据统计,2024年,中药材全产业链产值突破120亿元;2023年,全县药膳全产业链 产值达到31.4亿元。 除了药材和药膳,江南药乡还"卖"什么? 在中国磐安浙八味药材城的中药饮品店中,一款名为"沐春风"的饮品格外畅销。它融合桂圆、红枣、玫 瑰、枸杞,主打美容养颜功效;另一款"朝青丝"茶饮,则精准切入当代年轻人的护发需求,以养发黑发 为卖点,成为不少上班族的日常选择…… 此外,磐安的文旅体验也在不断深化,让药乡的魅力从"舌尖"延伸到" ...
创业板医药ETF(159377)涨超1.5%,政策红利与创新驱动或成行业支撑
Mei Ri Jing Ji Xin Wen· 2025-07-01 05:59
Group 1 - The pharmaceutical and biotechnology industry is experiencing rapid development supported by policies, with the innovative drug sector entering a commercialization phase [1] - In 2024, many companies are expected to significantly reduce losses, with high research and development enthusiasm for dual/multi-antibody drugs, ADCs, and gene therapies [1] - The medical device sector is seeing structural differentiation, with significant growth in bidding for medical devices expected in Q1 2025, particularly in medical imaging equipment, which is projected to grow over 85% [1] Group 2 - Policy documents such as "Opinions on Deepening the Reform of Drug and Medical Device Regulation to Promote High-Quality Development of the Pharmaceutical Industry" have been released, optimizing review and approval processes to support innovation [1] - The brain-computer interface and other new technologies are becoming important growth drivers, with national and local policies promoting their standardized development [1] - The traditional Chinese medicine sector is revitalizing through digital transformation, with new business models emerging under the "Traditional Chinese Medicine +" concept, and the potential for health consumption continues to be released [1] Group 3 - The industry as a whole benefits from an aging population, increased health awareness among residents, and policy dividends, although attention should be paid to risks such as centralized procurement price reductions and international competition [1] - The ChiNext Medical ETF tracks the ChiNext Medical Index, which is compiled by China Securities Index Co., Ltd., selecting listed companies in the biopharmaceutical, medical device, and medical service sectors from the ChiNext market to reflect the overall performance of high-growth, innovative enterprises [1]